Connecticut HB 6152: AN ACT REQUIRING THE INCLUSION OF METHADONE IN THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM.
Status: CHG. REF., SEN. TO COMM. ON General Law (as of 2019-02-06)
State: Connecticut · Session: 2019 · Bill: HB 6152
Subjects: Drugs, Methadone, Electronic medical records
Sponsors: Rutigliano, David
Bill Text
LCO No. 2063 1 of 1 General Assembly Proposed Bill No. 6152 January Session, 2019 LCO No. 2063 Referred to Committee on PUBLIC HEALTH Introduced by: REP. RUTIGLIANO, 123rd Dist. AN ACT REQUIRING THE INCLUSION OF METHADONE IN THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM. Be it enacted by the Senate and House of Representatives in General Assembly convened: That subsection (j) of section 21a-254 of the general statutes be 1 amended to require the Commissioner of Consumer Protection to 2 include methadone in the electronic prescription drug monitoring 3 program. 4 Statement of Purpose: To require the reporting of methadone prescriptions through the electronic prescription drug monitoring program.
View Connecticut HB 6152 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.